Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Destabilization of Microtubules01:45

Destabilization of Microtubules

2.8K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.8K
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

4.4K
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
4.4K
Microtubule Instability02:17

Microtubule Instability

5.2K
Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
5.2K
Microtubules01:35

Microtubules

87.6K
There are three types of cytoskeletal structures in eukaryotic cells—microfilaments, intermediate filaments, and microtubules. With a diameter of about 25 nm, microtubules are the thickest of these fibers. Microtubules carry out a variety of functions that include cell structure and support, transport of organelles, cell motility (movement), and the separation of chromosomes during cell division.
87.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Integrating Machine Learning and Structure-Guided Discovery of a Novel Type II SYK Inhibitor for Treating Triple-Negative Breast Cancer.

Journal of medicinal chemistry·2026
Same author

Design and Synthesis of USP1 Inhibitors: Synergistic Antitumor Activity with PARP Inhibitors in Triple-Negative Breast Cancer.

Journal of medicinal chemistry·2026
Same author

Structure-based design and synthesis of KX-01 analogs as potent antitumor agents targeting the tubulin colchicine binding site.

European journal of medicinal chemistry·2026
Same author

Feiwei Mixture Exerts Antitumor Activity Against Non-Small Cell Lung Cancer via Regulating NR1D1-Mediated Immune Cell Infiltration.

Advanced biology·2026
Same author

Rational Design of Novel pyrazolo[4,3-<i>c</i>]quinoline Derivatives as Potent, Selective, and Orally Bioavailable ATM Inhibitors with Promising <i>In Vivo</i> Efficacy.

Journal of medicinal chemistry·2026
Same author

Discovery of benzothiazole derivatives as novel orally receptor-interacting protein kinase 1 (RIPK1) inhibitors for inflammatory disease therapy.

European journal of medicinal chemistry·2025

相关实验视频

Updated: Jul 15, 2025

Preparation of Segmented Microtubules to Study Motions Driven by the Disassembling Microtubule Ends
12:20

Preparation of Segmented Microtubules to Study Motions Driven by the Disassembling Microtubule Ends

Published on: March 15, 2014

14.5K

微管降解剂的最新进展

Chufeng Zhang1, Min Zhao2, Guan Wang1

  • 1Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu 610041, Sichuan, China.

Journal of medicinal chemistry
|September 25, 2023
PubMed
概括

向蛋白降解 (TPD) 提供了一种通过降解疾病蛋白来对抗药物耐药性的新方法. 微管降解剂 (MDGA) 代表了一类新的TPD,克服了传统的微管向剂的局限性.

更多相关视频

Spatiotemporal Subcellular Manipulation of the Microtubule Cytoskeleton in the Living Preimplantation Mouse Embryo using Photostatins
08:13

Spatiotemporal Subcellular Manipulation of the Microtubule Cytoskeleton in the Living Preimplantation Mouse Embryo using Photostatins

Published on: November 30, 2021

2.5K
Quantitative Microtubule Fractionation Technique to Separate Stable Microtubules, Labile Microtubules, and Free Tubulin in Mouse Tissues
07:21

Quantitative Microtubule Fractionation Technique to Separate Stable Microtubules, Labile Microtubules, and Free Tubulin in Mouse Tissues

Published on: November 17, 2023

2.1K

相关实验视频

Last Updated: Jul 15, 2025

Preparation of Segmented Microtubules to Study Motions Driven by the Disassembling Microtubule Ends
12:20

Preparation of Segmented Microtubules to Study Motions Driven by the Disassembling Microtubule Ends

Published on: March 15, 2014

14.5K
Spatiotemporal Subcellular Manipulation of the Microtubule Cytoskeleton in the Living Preimplantation Mouse Embryo using Photostatins
08:13

Spatiotemporal Subcellular Manipulation of the Microtubule Cytoskeleton in the Living Preimplantation Mouse Embryo using Photostatins

Published on: November 30, 2021

2.5K
Quantitative Microtubule Fractionation Technique to Separate Stable Microtubules, Labile Microtubules, and Free Tubulin in Mouse Tissues
07:21

Quantitative Microtubule Fractionation Technique to Separate Stable Microtubules, Labile Microtubules, and Free Tubulin in Mouse Tissues

Published on: November 17, 2023

2.1K

科学领域:

  • 分子生物学分子生物学
  • 药物发现 药物发现 药物发现
  • 在瘤学瘤学.

背景情况:

  • 向蛋白质降解 (TPD) 利用细胞机械进行特定的蛋白质淘汰,通过降解整个蛋白质,比传统疗法提供优势.
  • 微管向剂 (MTA) 是已知的化疗药物,但临床使用受药物耐药性,过敏性和毒性限制.
  • 微管降解剂 (MDgAs) 是一种新的TPD方法,与MTA不同,旨在克服现有的抵抗机制.

研究的目的:

  • 总结微管降解剂 (MDGA) 的发展和机制.
  • 探索MDGA在克服传统微管向剂 (MTA) 的局限性方面的潜力.
  • 通过TPD讨论突素向药物发现领域的机遇和挑战.

主要方法:

  • 对针对性蛋白质降解 (TPD) 技术的现有文献的审查.
  • 对微管降解剂 (MDGA) 作用机制的分析.
  • MDgA机制与传统的微管向剂 (MTA) 的比较.

主要成果:

  • MDgAs通过TPD降解标蛋白,提供与MTAs不同的机制.
  • MDgAs显示出克服耐药性和减少与传统MTA相关的毒性.
  • MDgAs的开发扩大了TPD的范围,用于新型的氨酸向疗法.

结论:

  • 通过利用向蛋白质降解,MDgAs代表了癌症治疗的有希望的进步.
  • 这种方法提供了一个可行的策略,以克服当前针对微管的药物固有的耐药性和毒性问题.
  • 对MDgAs的进一步研究为开发下一代抗癌疗法提供了显著的潜力.